Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-11-10
著者
-
Honma Yoshio
Department Of Life Science Shimane University Faculty Of Medicine
-
Honma Yoshio
Department Of Chemotherapy Saitama Cancer Center Research Institute
-
AKIMOTO Miho
Department of Life Science, Shimane University Faculty of Medicine
-
Akimoto Miho
Department Of Life Science Shimane University Faculty Of Medicine
-
HONMA Yoshio
Department of Life Science, Shimane University Faculty of Medicine
関連論文
- Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia
- Effects of Hibarimicins and Hibarimicin-Related Compounds Produced by Microbispora on v-Src Kinase Activity and Growth and Differentiation of Human Myeloid Leukemia HL-60 Cells
- Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells
- Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production
- Clinical significance of serum NM23-H1 protein in neuroblastoma
- Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2
- Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents
- Influence of Castration on RNase Activity in Rat Ventral Prostate
- Hormone Action in the Nucleus : Role of the Cytoplasm